BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38575419)

  • 1. Radiogenomics is Elevating Treatment Response Prediction in Head and Neck Squamous Cell Carcinoma.
    Zhang Z; Lu Y
    Acad Radiol; 2024 Jun; 31(6):2476-2477. PubMed ID: 38575419
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiomics and radiogenomics in head and neck squamous cell carcinoma: Potential contribution to patient management and challenges.
    Bruixola G; Remacha E; Jiménez-Pastor A; Dualde D; Viala A; Montón JV; Ibarrola-Villava M; Alberich-Bayarri Á; Cervantes A
    Cancer Treat Rev; 2021 Sep; 99():102263. PubMed ID: 34343892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine Learning-Based MRI Radiogenomics for Evaluation of Response to Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma.
    Li Z; Wang R; Wang L; Tan C; Xu J; Fang J; Xian J
    Acad Radiol; 2024 Jun; 31(6):2464-2475. PubMed ID: 37985290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and genomic characterization of neutral tumor evolution in Head and Neck Squamous Cell Carcinoma.
    Li R; Dong J; Zhang H; Zhao Q; Li X; Liu X; Ye Y; Deng S; Lin D; Zheng J; Zuo Z
    Genomics; 2020 Sep; 112(5):3448-3454. PubMed ID: 32569729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DAHANCA 33: functional image-guided dose-escalated radiotherapy to patients with hypoxic squamous cell carcinoma of the head and neck (NCT02976051).
    Saksø M; Primdahl H; Johansen J; Nowicka-Matus K; Overgaard J;
    Acta Oncol; 2020 Feb; 59(2):208-211. PubMed ID: 31805799
    [No Abstract]   [Full Text] [Related]  

  • 6. Diffusion tensor imaging in differentiation of residual head and neck squamous cell carcinoma from post-radiation changes.
    Abdel Razek AAK
    Magn Reson Imaging; 2018 Dec; 54():84-89. PubMed ID: 30142392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron Emission Tomography-Computed Tomography Imaging, Genomic Profile, and Survival in Patients With Head and Neck Cancer Receiving Immunotherapy.
    Fitzgerald CWR; Valero C; Swartzwelder CE; Morris LGT
    JAMA Otolaryngol Head Neck Surg; 2021 Dec; 147(12):1119-1120. PubMed ID: 34297796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Genetic Alterations in Oncogenic Signaling Pathways in Squamous Cell Carcinoma of the Head and Neck: Radiogenomic Analysis Based on Computed Tomography Images.
    Wu L; Lin P; Zhao Y; Li X; Yang H; He Y
    J Comput Assist Tomogr; 2021 Nov-Dec 01; 45(6):932-940. PubMed ID: 34469904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of lymphatic metastasis and progression patterns for clinical target volume (CTV) definition in head and neck squamous cell carcinoma (HNSCC).
    Pouymayou B; Koechli C; Balermpas P; Guckenberger M; Unkelbach J
    Acta Oncol; 2019 Oct; 58(10):1519-1522. PubMed ID: 31364898
    [No Abstract]   [Full Text] [Related]  

  • 10. Distortion correction of diffusion-weighted magnetic resonance imaging of the head and neck in radiotherapy position.
    Winter RM; Schmidt H; Leibfarth S; Zwirner K; Welz S; Schwenzer NF; la Fougère C; Nikolaou K; Gatidis S; Zips D; Thorwarth D
    Acta Oncol; 2017 Nov; 56(11):1659-1663. PubMed ID: 28927335
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative ultrasound radiomics in predicting recurrence for patients with node-positive head-neck squamous cell carcinoma treated with radical radiotherapy.
    Dasgupta A; Fatima K; DiCenzo D; Bhardwaj D; Quiaoit K; Saifuddin M; Karam I; Poon I; Husain Z; Tran WT; Sannachi L; Czarnota GJ
    Cancer Med; 2021 Apr; 10(8):2579-2589. PubMed ID: 33314716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis, Staging, Radiation Treatment Response Assessment, and Outcome Prognostication of Head and Neck Cancers Using PET Imaging: A Systematic Review.
    Hohenstein NA; Chan JW; Wu SY; Tahir P; Yom SS
    PET Clin; 2020 Jan; 15(1):65-75. PubMed ID: 31735303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Utility of Interim Positron Emission Tomography Imaging to Inform Adaptive Radiotherapy for Head and Neck Squamous Cell Carcinoma.
    Rosen BS; Vaishampayan N; Cao Y; Mierzwa ML
    Cancer J; 2023 Jul-Aug 01; 29(4):243-247. PubMed ID: 37471616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor to cervical spinal cord standardized uptake ratio (SUR) improves the reproducibility of
    van den Bosch S; Dijkema T; Philippens MEP; Terhaard CHJ; Hoebers FJP; Kaanders JHAM; Oyen WJG
    Radiother Oncol; 2019 Jan; 130():39-45. PubMed ID: 30005954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer.
    Sanli Y; Zukotynski K; Mittra E; Chen DL; Nadel H; Niederkohr RD; Subramaniam RM
    Clin Nucl Med; 2018 Dec; 43(12):e439-e452. PubMed ID: 30394934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
    Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
    J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiomic Application for Head and Neck Squamocellular Tumor: Systematic Review.
    Messineo D; Massaro F; Izzo P; Milani A; Polimeni R; Iannella G; Marinozzi S; Consorti F; Cocuzza S; Maniaci A; Mucchino A; Nannarelli M; Greco A; Magliulo G; Salducci M; Pace A
    Clin Ter; 2024; 175(2):153-160. PubMed ID: 38571474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioresistance and genomic alterations in head and neck squamous cell cancer: Sub-analysis of the ProfiLER protocol.
    Rowinski E; Magné N; Fayette J; Daguenet E; Racadot S; Pommier P; Méry B; Vallard A; Tinquaut F; Neidhardt-Berard EM; Cassier P; Attignon V; Pissaloux D; Wang Q; Sohier E; Pérol D; Blay JY; Trédan O
    Head Neck; 2021 Dec; 43(12):3899-3910. PubMed ID: 34643313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of long non-coding RNA LINC00520 promotes radiosensitivity of head and neck squamous cell carcinoma cells.
    Li J; Liu X; Nan S; Xu C
    Free Radic Res; 2020 Apr; 54(4):254-270. PubMed ID: 32462956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A subregion-based prediction model for local-regional recurrence risk in head and neck squamous cell carcinoma.
    Pan Z; Men K; Liang B; Song Z; Wu R; Dai J
    Radiother Oncol; 2023 Jul; 184():109684. PubMed ID: 37120101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.